Seventh Sense Adventures Holding AB to remain a long term investor in Redsense Medical AB

Patrik Byhmer, former Chairman of the Board and founder, was before his passing the largest owner of Redsense Medical with the majority of the shares held through Seventh Sense Adventures Holding AB.

Susanne Olauson and Fanny Byhmer Svensson, members of the Board of Seventh Sense Adventures Holding, wish to share the following:

“We will continue to support Patrik’s mission to improve patient safety in hemodialysis and saving lives. Seventh Sense Adventures Holding AB has no intention to sell any shares and remain determined to turn Redsense Medical into a profitable company as per Patrik’s vision.”

Contact information

For more information, please contact: 
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector. The Redsense Medical share is listed on Spotlight Stock Market (REDS) and traded on OTCQX (RDSNF) in the US.